Motiva® Implants Overview
Explore our breast reconstruction and augmentation solutions designed with high-end technology and research-based knowledge focused on improving patient safety and aesthetic outcomes.
Technology
INCLUDED
ADD-ONS
Motiva® Round Plus
- TrueMonobloc® - ProgressiveGel® PLUS - BluSeal® - SmoothSilk®/SilkSurface®
- Product Replacement Policy - Always Confident Warranty® - RFID Enabled Implant (Qid®)
- RFID-Enabled Implant (Qid®) - Motiva MinimalScar® - 2Y Extended Warranty* - 5Y Extended Warranty**
Motiva Ergonomix®
- TrueMonobloc® - ProgressiveGel® ULTIMA - BluSeal® - SmoothSilk®/SilkSurface®
- Product Replacement Policy - Always Confident Warranty® - RFID Enabled Implant (Qid®)
- RFID-Enabled Implant (Qid®) - MotivaHybrid® - Motiva MinimalScar® - 2Y Extended Warranty* - 5Y Extended Warranty**
Motiva Ergonomix2®
- Motiva SuperSilicones® - TrueMonobloc+® - ProgressiveGel Ultima® - BluSeal+® - SmoothSilk®/SilkSurface®
- JOY® Program • Woman’s Choice Program® • 5Y Extended Warranty - RFID-Enabled Implant (Qid®) - Product Replacement Policy - Always Confident Warranty®
- MotivaHybrid® - Motiva MinimalScar®
*Add-on option for implants without Qid®
**Add-on option for implants with Qid®
Breast Optimization
More about implant technology
Motiva SuperSilicones®
Breast implant shell quality is an essential safety feature and is also key to providing flexibility and other mechanical properties crucial for the device’s performance.4
With the Ergonomix2® implants, Motiva® is introducing a new silicone formulation and shell configuration that improves elongation,5 enhancing its ability to adapt to changes.
Why is this important? The ability to bend easily is essential for the implant to be introduced through small incisions. Ergonomix2® is an implant designed to enhance minimally invasive techniques like Motiva MinimalScar®.
TrueMonobloc+®
This feature is a proprietary technology that links the components of the shell and the filling gel to create a more cohesive structure.1
The interaction between the unique features of the components in Ergonomix2® maximizes its bonding properties while conferring the system with more flexibility and adaptability. This gives rise to an upgraded version named TrueMonobloc+®.
Ergonomix2® implants can be compressed to a higher degree than our trusted high-performing Ergonomix®, thus facilitating the insertion of the device through smaller incisions.6
BluSeal+®
For more than three decades, technology advancements have led to a significant improvement in control of silicone diffusion from breast implants.7
Our safety barrier layer is one-of-a-kind. It is a lightly tinted, blue-barrier layer made with biocompatible dyes to allow for pre-surgical visual inspection.1
BluSeal+® improves the performance of an already outstanding safety feature.8
ProgressiveGel Ultima®
Natural tissue dynamics resemblance has been the key missing factor in traditional implants due to their predefined shape, which remains unaltered whether the patient is standing up, inclined or lying down.
Motiva® incorporates this organic movement characteristic into Ergonomix2® through the unique viscoelastic properties of the Ultima® gel – holding a round shape when the patient is lying down and forming a natural looking teardrop shape when she is standing.9
The outcome is a gel created with a unique set of properties that provide a better adaptation to movement than other silicone gels tested, resembling the mobility of natural tissue.1
SmoothSilk®/SilkSurface®
An advanced smooth surface designed to enhance biocompatibility.2
Ergonomix2® comes with
SmoothSilk®/SilkSurface®, a controlled uniform
surface designed and demonstrated to:
• Mitigate the inflammatory and fibrotic response of your body.10
• Limit bacterial load, reducing the risk of biofilm formation.11
• Reduce the prevalence of chronic inflammatory complications, such as
double capsules and late seromas.12
RFID-enabled Implants
The electronic serial number (ESN) and related information about your implants is kept safely through a battery-free and passive radiofrequency identification device3: our Qid®.
This first-of-its-kind safety technology allows your healthcare provider to use an external, hand-held reader to identify details about your Motiva Implants after surgery, even if your printed implant ID card isn’t available.
Did you know?
A most recent study performed at the Koch Institute from MIT, published in the Nature Biomedical Engineering Journal, observed in vivo physiological and immune responses in mice, rabbits, and explanted capsules from human models with different silicone breast implant surface architectures, ranging from traditional smooth, to advanced smooth, to micro or macro/heavily textured.2
Findings suggest that SmoothSilk®/SilkSurface® implants showed improved biocompatibility as:
- SmoothSilk®/SilkSurface® provoked the less pro-fibrotic inflammation and FBR across mouse and rabbit models and human capsules.
- Its profile is characterized by a low inflammatory cell infiltrate and anti-fibrotic gene expression.
- This in turn should minimize foreign body immune-related complications, such as capsular contracture, malposition, seroma, double capsule, and BIA-ALCL.2
Why Motiva®
References
1 Data on file. Establishment Labs®.
2 Doloff JC, Veiseh O, de Mezerville R, et al. The surface topography of silicone breast implants mediates the foreign body response in mice, rabbits and humans. Nature Biomedical Engineering. 2021;5(10):1115-1130. doi:10.1038/s41551-021-00739-4
3 Nelson MT, Brattain KA, Williams JM. Does Electronic Identification Enablement for Silicone Gel Implants Impact Patient Safety? J Surg Open Access. 2018;4(1):1-7. doi:10.16966/2470-0991.162
4 Patrick Maxwell G, Gabriel A. Breast implant design. Gland Surg. 2017;6(2):148-153. doi:10.21037/gs.2016.11.09
5 Establishment Labs. TS-001196. Mar, 2021.
6 Establishment Labs. TS-000212. Mar, 2021
7 Spear SL, Jespersen MR. Breast implants: Saline or silicone? Aesthetic Surg J. 2010;30(4):557-570. doi:10.1177/1090820X10380401
8 Establishment Labs. TSD-001008. Nov, 2020.
9 Pluris Research Inc. ELABS2. Apr, 2018.
10 Quirós MC, Bolaños MC, Fassero JJ. Six-year prospective outcomes of primary breast augmentation with nano surface implants. Aesthetic Surg J. 2019;39(5):495-508. doi:10.1093/asj/sjy196
11 James GA, Boegli L, Hancock J, Bowersock L, Parker A, Kinney BM. Bacterial Adhesion and Biofilm Formation on Textured Breast Implant Shell Materials. Aesthetic Plast Surg. 2019;43(2):490-497. doi:10.1007/s00266-018-1234-7
12 Sforza M, Zaccheddu R, Alleruzzo A, et al. Preliminary 3-Year Evaluation of Experience with SilkSurface and VelvetSurface Motiva Silicone Breast Implants: A Single-Center Experience with 5813 Consecutive Breast Augmentation Cases. Aesthetic Surg J. 2018;38:S62-S73. doi:10.1093/asj/sjx15
